Evidence map›Paper›PMID 23988345›Full record

ArticlePhysiology & behavior2013

CCK response in bulimia nervosa and following remission.

Sandra L Hannon-Engel, Evgeniy E Filin, Barbara E Wolfe

Open access · greenAbstract read
In one paragraph

Article in Physiology & behavior, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Cholecystokinin: Clinical aspects of the new biology.Journal of internal medicine · 2025
    Review
  2. Review
  3. Emerging Treatments in Eating Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sandra L Hannon-EngelWilliam F. Connell School of Nursing, Boston College, Chestnut Hill, MA, United States. Electronic address: hannonen@bc.edu.
Evgeniy E Filin
Barbara E Wolfe
Boston College · USBeth Israel Deaconess Medical Center · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Role of Altered CCK Response in Bulimia NervosaF31NR010453 · NINR · BOSTON COLLEGE · PI HANNON-ENGEL, SANDRA L. · 2008 to 2010
$98k
NCRR NIH HHS UL1 RR025758NINR NIH HHS F31 NR010453NINR NIH HHS F31NR010453
6 · The paper itself

Abstract

The core defining features of bulimia nervosa (BN) are repeated binge eating episodes and inappropriate compensatory (e.g., purging) behavior. Previous studies suggest an abnormal post-prandial response in the satiety-signaling peptide cholecystokinin (CCK) in persons with BN. It is unknown whether this altered response persists following remission or if it may be a potential target for the development of clinical treatment strategies. To examine the nature of this altered response, this study assessed whether CCK normalizes following remission from BN (RBN). This study prospectively evaluated the plasma CCK response and corresponding eating behavior-related ratings (e.g., satiety, fullness, hunger, urge to binge and vomit) in individuals with BN-purging subtype (n=10), RBN-purging subtype (n=14), and healthy controls (CON, n=13) at baseline, +15, +30, and +60 min following the ingestion of a standardized liquid test meal. Subject groups did not significantly differ in CCK response to the test meal. A significant relationship between CCK response and satiety ratings was observed in the RBN group (r=.59, p<.05 two-tailed). A new and unanticipated finding in the BN group was a significant relationship between CCK response and ratings of "urge to vomit" (r=.86, p<.01, two-tailed). Unlike previous investigations, CCK response did not differ in BN and CON groups. Thus the role of symptom severity remains an area of further investigation. Additionally, findings suggest that in this sample, CCK functioning following remission from BN-purging subtype is not different from controls. It remains unknown whether or not CCK functioning may be a protective or liability factor in the stabilization and recovery process. Replication studies utilizing a larger sample size are needed to further elucidate the role of CCK in recovery from BN and its potential target of related novel treatment strategies.

Indexed as

AdolescentAdultBulimiaBulimia NervosaCholecystokininEatingFemaleHumansHungerMiddle AgedPostprandial PeriodProspective StudiesSatiationCholecystokininBinge eatingBulimia nervosaCCKEating behaviorEating disorderPurgingSatiety

Identifiers

PMID23988345
PMCPMC4395462
OpenAlexW1988650770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.